New drug-testing tech could drastically cut animal testing
Israeli human-on-a-chip platform has the unique ability to predict risk of toxicity in pharma and cosmetic product candidates without animal testing.
Israeli human-on-a-chip platform has the unique ability to predict risk of toxicity in pharma and cosmetic product candidates without animal testing.
In her lab at Hadassah Medical Center’s gene therapy institute, Rinat Abramovitch discovered why fresh vs. donor blood is better for liver surgery patients.
Weizmann Institute of Science researchers say eating at the right time could reduce levels of triglycerides in the liver.
The world’s only third-generation inoculation against this widespread virus comes from an Israeli pharmaceutical company.
Groundbreaking advance clears the way for future medications to better target a deadly problem.